BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 394186)

  • 21. [New cardiotonic/inodilator agents: energetic aspects].
    Hasenfuss G
    Z Kardiol; 1992; 81 Suppl 4():57-63. PubMed ID: 1290307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [State of the myocardium outside the infarct zone].
    Vikhert AM; Cherpachenko NM
    Ter Arkh; 1981; 53(4):38-49. PubMed ID: 6167006
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of dobutamine on coronary circulation and cardiac metabolism of the dog.
    Sakanashi M; Tomomatsu E; Takeo S; Araki H; Iwasaki K; Sakamoto K; Takenaka F
    Arzneimittelforschung; 1978; 28(5):798-801. PubMed ID: 581958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest.
    de Wit L; Coetzee A; Kotze J; Lochner A
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):310-20. PubMed ID: 3339898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of catecholamine effects on canine myocardial metabolism and regional blood flow during and after cardiopulmonary bypass.
    Ward HB; Einzig S; Wang T; Bianco RW; Foker JE
    J Thorac Cardiovasc Surg; 1984 Mar; 87(3):452-65. PubMed ID: 6700252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolic processes in the myocardium during the early stages of postnatal ontogenesis and the effect of cardiac glycosides (review of the literature)].
    Chekman IS; Viktorov AP
    Farmakol Toksikol; 1978; 41(6):723-30. PubMed ID: 363451
    [No Abstract]   [Full Text] [Related]  

  • 27. Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion.
    Lazar HL; Buckberg GD; Manganaro AM; Becker H
    J Thorac Cardiovasc Surg; 1980 Sep; 80(3):350-9. PubMed ID: 7412340
    [No Abstract]   [Full Text] [Related]  

  • 28. Perfusion preservation maintains myocardial ATP levels and reduces apoptosis in an ex vivo rat heart transplantation model.
    Peltz M; He TT; Adams GA; Koshy S; Burgess SC; Chao RY; Meyer DM; Jessen ME
    Surgery; 2005 Oct; 138(4):795-805. PubMed ID: 16269311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early abnormalities in myocardial cell function in experimental diabetes.
    Gøtzsche O
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 2():1-21. PubMed ID: 3017048
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of superoxide dismutase and catalase on myocardial energy metabolism during ischemia and reperfusion.
    Das DK; Engelman RM; Otani H; Rousou JA; Breyer RH; Lemeshow S
    Clin Physiol Biochem; 1986; 4(3):187-98. PubMed ID: 3709036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The calcium paradox: metabolic, electrophysiological, contractile and ultrastructural characteristics in four species.
    Hearse DJ; Humphrey SM; Boink AB; Ruigrok TJ
    Eur J Cardiol; 1978 Jun; 7(4):241-56. PubMed ID: 689059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB; Mody FV; Krivokapich J; Schelbert HR
    J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contractile function, energy metabolism and myocardial structure at graded restriction of coronary blood flow.
    Furkalo NK; Frolkis RA; Orlova NN; Gavrish AS
    Cor Vasa; 1982; 24(5):372-80. PubMed ID: 7172690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of drugs on enzyme release from the hypoxic myocardium.
    Hearse DJ; Garlick PB; Humphrey SM; Shillingford JP
    Eur J Cardiol; 1978 Jul; 7(5-6):421-36. PubMed ID: 699942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The prolongation of the survival time of ischemic hearts by perfusing the coronary arteries with gaseous oxygen].
    Arnold G; Müller-Ruchholtz ER; Lochner W
    Arztl Forsch; 1968 Aug; 22(8):257-64. PubMed ID: 5754867
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathophysiological causal-factors of myocardial necrosis and infarct].
    Fleckenstein A
    Wien Z Inn Med; 1971 Mar; 52(3):133-43. PubMed ID: 4941803
    [No Abstract]   [Full Text] [Related]  

  • 37. [The role of feedback in myocardial ischemia].
    Starcich R
    Minerva Cardioangiol; 1979; 27(1-2):13-6. PubMed ID: 157444
    [No Abstract]   [Full Text] [Related]  

  • 38. [Proceedings: Disorders of the myocardial metabolism in coronary disease].
    Kübler W
    Med Klin; 1975 Jun; 70(23):1012. PubMed ID: 1637
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dynamic energy participation in electrogenesis of the myocardium (author's transl)].
    Goto M; Tsuda Y; Yatani A
    Nihon Seirigaku Zasshi; 1975; 37(11):345-58. PubMed ID: 176348
    [No Abstract]   [Full Text] [Related]  

  • 40. The ischemic myocardium: mechanism of early pump failure.
    Katz AM
    Hosp Pract; 1978 Jun; 13(6):83-91. PubMed ID: 689672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.